FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

3rd Party Inspection Findings Hits Regeneron BLA

[ Price : $8.95]

An FDA inspection at a third-party manufacturer cites inspection issues that have resulted in a complete response letter on a Regn...

ICH Pediatric Extrapolation Guidance

[ Price : $8.95]

FDA publishes the International Council for Harmonization E11A guidance intended to recommend and harmonize pediatric extrapolatio...

FDA Clears Nanox AI Cardiac Solution

[ Price : $8.95]

FDA clears the Nanox HealthCCSng V2.0 artificial intelligence coronary solution to help detect coronary artery calcium.

Over 1,000 BIMO Inspections in FY 2023

[ Price : $8.95]

An FDA report on bioresearch monitoring FY 2023 metrics documents nearly 1,100 inspections through FDAs five Centers.

Novartis Wins Generic Entresto Approval Stay

[ Price : $8.95]

The United States Court of Appeals for the DC Circuit grants a Novartis motion to stay FDAs approval of MSN Laboratories generic v...

FTC Supports FDA Draft on Interchangeable Biosimilars

[ Price : $8.95]

The Federal Trade Commission says it supports an FDA draft guidance easing the approval requirements for interchangeable biosimila...

GAO Sees Actions, Challenges in Device Surveillance

[ Price : $8.95]

The Government Accountability Office says FDA has faced challenges in its preparations for beginning active postmarket surveillanc...

Reps Seek FDA Action on Drug Research in China

[ Price : $8.95]

Four House Democrats and Republicans urge FDA to take a greater role in protecting U.S. national security interests that could be ...

Significant CGMP Violations at Eugia Pharma

[ Price : $8.95]

FDA warns Indias Eugia Pharma Specialties about CGMP violations in its production of finished drugs.

LDT Power Grab Suit Filed Against FDA

[ Price : $8.95]

The Association for Molecular Pathology and a pathologist sue FDA to block implementation of the agencys final rule asserting regu...